Dysmagnesemia in Hospitalized Patients: Prevalence and Prognostic Importance

Mayo Clinic Proceedings

Volumn 90, Issue 8, 2015, Pages 1001-1010

  Cheungpasitporn, Wisit ^a   Thongprayoon, Charat ^a,b   Qian, Qi ^a  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF UROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; MAGNESIUM; PHOSPHORUS; POTASSIUM;

ADULT; AGED; ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DYSMAGNESEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERMAGNESEMIA; HYPOMAGNESEMIA; LABORATORY TEST; LENGTH OF STAY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES; BLOOD; COHORT ANALYSIS; COMPLICATION; HOSPITALIZATION; MAGNESIUM DEFICIENCY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84938604372     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.04.023     Document Type: Article

References (68)

1. B.M. Altura Basic biochemistry and physiology of magnesium: a brief review Magnes Trace Elem 10 2-4 1991-1992 167 171
2. D.T. Dibaba, P. Xun, and K. He Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review [published correction appears in Eur J Clin Nutr. 2015;69(3):410] Eur J Clin Nutr 68 4 2014 510 516
3. M.B. Schulze, M. Schulz, C. Heidemann, A. Schienkiewitz, K. Hoffmann, and H. Boeing Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis Arch Intern Med 167 9 2007 956 965
4. R.J. Belin, and K. He Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome Magnes Res 20 2 2007 107 129
5. X. Qu, F. Jin, Y. Hao, and et al. Nonlinear association between magnesium intake and the risk of colorectal cancer Eur J Gastroenterol Hepatol 25 3 2013 309 318
6. S.C. Larsson, N. Orsini, and A. Wolk Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies Am J Clin Nutr 95 2 2012 362 366
7. X. Qu, F. Jin, Y. Hao, and et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies PLoS One 8 3 2013 e57720
8. M. Safavi, and A. Honarmand Admission hypomagnesemia - impact on mortality or morbidity in critically ill patients Middle East J Anaesthesiol 19 3 2007 645 660
9. L.C. Del Gobbo, F. Imamura, J.H. Wu, M.C. de Oliveira Otto, S.E. Chiuve, and D. Mozaffarian Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies Am J Clin Nutr 98 1 2013 160 173
10. M. Rodríguez-Morán, and F. Guerrero-Romero Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial Diabetes Care 26 4 2003 1147 1152
11. F. Guerrero-Romero, and M. Rodríguez-Morán Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial Eur J Clin Invest 41 4 2011 405 410
12. Y. Sakaguchi, N. Fujii, T. Shoji, T. Hayashi, H. Rakugi, and Y. Isaka Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis Kidney Int 85 1 2014 174 181
13. C. Courivaud, and A. Davenport Magnesium and the risk of all-cause and cardiac mortality in hemodialysis patients: agent provocateur or innocent bystander? Kidney Int 85 1 2014 17 20
14. F. Turgut, M. Kanbay, M.R. Metin, E. Uz, A. Akcay, and A. Covic Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis Int Urol Nephrol 40 4 2008 1075 1082
15. E.A. Kupetsky-Rincon, Q. Li, and J. Uitto Magnesium reduces carotid intima-media thickness in a mouse model of pseudoxanthoma elasticum: a novel treatment biomarker Clin Transl Sci 5 3 2012 259 264
16. M. Shechter, M. Sharir, M.J. Labrador, J. Forrester, B. Silver, and C.N. Bairey Merz Oral magnesium therapy improves endothelial function in patients with coronary artery disease Circulation 102 19 2000 2353 2358
17. J.A. Maier Endothelial cells and magnesium: implications in atherosclerosis Clin Sci (Lond) 122 9 2012 397 407
18. H.S. Rüfenacht, and H. Fleisch Measurement of inhibitors of calcium phosphate precipitation in plasma ultrafiltrate Am J Physiol 246 5, pt 2 1984 F648 F655
19. A.C. Montezano, D. Zimmerman, H. Yusuf, and et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium Hypertension 56 3 2010 453 462
20. F. Kircelli, M.E. Peter, E. Sevinc Ok, and et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner Nephrol Dial Transplant 27 2 2012 514 521
21. M. Charlson, T.P. Szatrowski, J. Peterson, and J. Gold Validation of a combined comorbidity index J Clin Epidemiol 47 11 1994 1245 1251
22. Harrell FE Jr. rms: Regression Modeling Strategies. R package version 4.3-0. http://CRAN.R-project.org/package=rms. Published January 5, 2015. Accessed January 20, 2015.
23. P.-C.T. Pham, P.-M.T. Pham, S.V. Pham, J.M. Miller, and P.-T.T. Pham Hypomagnesemia in Patients with type 2 diabetes Clin J Am Soc Nephrol 2 2 2007 366 373
24. D. Deheinzelin, E.M. Negri, M.R. Tucci, and et al. Hypomagnesemia in critically ill cancer patients: a prospective study of predictive factors Braz J Med Biol Res 33 12 2000 1443 1448
25. L. Henry, L. Halpin, S. Hunt, S.D. Holmes, and N. Ad Patient disposition and long-term outcomes after valve surgery in octogenarians Ann Thorac Surg 94 3 2012 744 750
26. R. Mehrotra, C.A. Peralta, S.C. Chen, et al. Kidney Early Evaluation Program (KEEP) Investigators No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease Kidney Int 84 5 2013 989 997
27. H.L. Palomino, D.E. Rifkin, C. Anderson, M.H. Criqui, M.A. Whooley, and J.H. Ix 24-Hour urine phosphorus excretion and mortality and cardiovascular events Clin J Am Soc Nephrol 8 7 2013 1202 1210
28. S.C. Palmer, A. Hayen, P. Macaskill, and et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis JAMA 305 11 2011 1119 1127
29. C.S. Limaye, V.A. Londhey, M.Y. Nadkart, and N.E. Borges Hypomagnesemia in critically ill medical patients J Assoc Physicians India 59 2011 19 22
30. H.J. Milionis, G.E. Alexandrides, E.N. Liberopoulos, E.T. Bairaktari, J. Goudevenos, and M.S. Elisaf Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure Eur J Heart Fail 4 2 2002 167 173
31. A.M. Khan, S.A. Lubitz, L.M. Sullivan, and et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study Circulation 127 1 2013 33 38
32. M.F. McCarty Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate Med Hypotheses 46 2 1996 89 100
33. Y. Yamori, T. Taguchi, H. Mori, and M. Mori Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world J Biomed Sci 17 suppl 1 2010 S21
34. G. Rolla, C. Bucca, M. Bugiani, A. Oliva, and L. Branciforte Hypomagnesemia in chronic obstructive lung disease: effect of therapy Magnes Trace Elem 9 3 1990 132 136
35. M. Tam, S. Gómez, M. González-Gross, and A. Marcos Possible roles of magnesium on the immune system Eur J Clin Nutr 57 10 2003 1193 1197
36. L. Galland Magnesium and immune function: an overview Magnesium 7 5-6 1988 290 299
37. F.Y. Li, B. Chaigne-Delalande, C. Kanellopoulou, and et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency Nature 475 7357 2011 471 476
38. E.M. Skobeloff, W.H. Spivey, R.M. McNamara, and L. Greenspon Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department JAMA 262 9 1989 1210 1213
39. R. Mathew, and B.M. Altura The role of magnesium in lung diseases: asthma, allergy and pulmonary hypertension Magnes Trace Elem 10 2-4 1991-1992 220 228
40. C. Powell, K. Dwan, S.J. Milan, and et al. Inhaled magnesium sulfate in the treatment of acute asthma Cochrane Database Syst Rev 12 2012 CD003898
41. S. Goodacre, J. Cohen, M. Bradburn, A. Gray, J. Benger, T. Coats 3Mg Research Team Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial Lancet Respir Med 1 4 2013 293 300
42. K. Wyskida, J. Witkowicz, J. Chudek, and A. Wiecek Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease J Ren Nutr 22 1 2012 19 26
43. A.C. Alfrey, N.L. Miller, and R. Trow Effect of age and magnesium depletion on bone magnesium pools in rats J Clin Invest 54 5 1974 1074 1081
44. A.C. Alfrey, N.L. Miller, and D. Butkus Evaluation of body magnesium stores J Lab Clin Med 84 2 1974 153 162
45. J. Ayuk, and N.J. Gittoes Treatment of hypomagnesemia Am J Kidney Dis 63 4 2014 691 695
46. R.E. White, and H.C. Hartzell Magnesium ions in cardiac function: regulator of ion channels and second messengers Biochem Pharmacol 38 6 1989 859 867
47. J. Li, M.S. Imtiaz, N.A. Beard, and et al. β-Adrenergic stimulation increases RyR2 activity via intracellular Ca2+ and Mg2+ regulation PLoS One 8 3 2013 e58334
48. D.R. Laver, and B.N. Honen Luminal Mg2+, a key factor controlling RYR2-mediated Ca2+ release: cytoplasmic and luminal regulation modeled in a tetrameric channel J Gen Physiol 132 4 2008 429 446
49. K. Gusev, and E. Niggli Modulation of the local SR Ca2+ release by intracellular Mg2+ in cardiac myocytes J Gen Physiol 132 6 2008 721 730
50. L.T. Iseri, J. Freed, and A.R. Bures Magnesium deficiency and cardiac disorders Am J Med 58 6 1975 837 846
51. H.S. Friedman, T.N. Nguyen, A.M. Mokraoui, R.L. Barbour, T. Murakawa, and B.M. Altura Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog J Pharmacol Exp Ther 243 1 1987 126 130
52. M. Barbagallo, L.J. Dominguez, A. Galioto, A. Pineo, and M. Belvedere Oral magnesium supplementation improves vascular function in elderly diabetic patients Magnes Res 23 3 2010 131 137
53. J.A. Maier, C. Malpuech-Brugère, W. Zimowska, Y. Rayssiguier, and A. Mazur Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis Biochim Biophys Acta 1689 1 2004 13 21
54. B.F. Dickens, W.B. Weglicki, Y.S. Li, and I.T. Mak Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells FEBS Lett 311 3 1992 187 191
55. M. Kanbay, D. Goldsmith, M.E. Uyar, F. Turgut, and A. Covic Magnesium in chronic kidney disease: challenges and opportunities Blood Purif 29 3 2010 280 292
56. C.M. Champagne Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review Nutr Clin Pract 23 2 2008 142 151
57. L.S. Hadjistavri, P.A. Sarafidis, P.I. Georgianos, and et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile Med Sci Monit 16 6 2010 CR307 CR312
58. K. Kisters Oral magnesium supplementation improves borderline hypertension [letter] Magnes Res 24 2011 17
59. P.S. Patki, J. Singh, S.V. Gokhale, P.M. Bulakh, D.S. Shrotri, and B. Patwardhan Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study BMJ 301 6751 1990 521 523
60. M.C. Houston The importance of potassium in managing hypertension Curr Hypertens Rep 13 4 2011 309 317
61. S.C. Larsson, J. Virtamo, and A. Wolk Potassium, calcium, and magnesium intakes and risk of stroke in women Am J Epidemiol 174 1 2011 35 43
62. T. Reffelmann, M. Dörr, T. Ittermann, and et al. Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors Atherosclerosis 213 2 2010 563 569
63. T. Ohira, J.M. Peacock, H. Iso, L.E. Chambless, W.D. Rosamond, and A.R. Folsom Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study Am J Epidemiol 169 12 2009 1437 1444
64. A.M. Khan, L. Sullivan, E. McCabe, D. Levy, R.S. Vasan, and T.J. Wang Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease Am Heart J 160 4 2010 715 720
65. N.E. Saris, E. Mervaala, H. Karppanen, J.A. Khawaja, and A. Lewenstam Magnesium: an update on physiological, clinical and analytical aspects Clin Chim Acta 294 1-2 2000 1 26
66. R.K. Rude Magnesium metabolism and deficiency Endocrinol Metab Clin North Am 22 2 1993 377 395
67. J.L. Nadler, and R.K. Rude Disorders of magnesium metabolism Endocrinol Metab Clin North Am 24 3 1995 623 641
68. E. Ryzen, N. Elbaum, F.R. Singer, and R.K. Rude Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency Magnesium 4 2-3 1985 137 147